10 Best Growth Stocks Under $20 to Buy
On May 29, Scott Wren, Senior Global Market Strategist at Wells Fargo Investment Institute, joined BNN Bloomberg to discuss the markets.
Monte Rosa Therapeutics Inc. (GLUE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 4,460,886 | $73,381,575 | +17% | 2.34% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 4,345,736 | $71,487,357 | 0.41% | |
| 3. | Suvretta Capital Management Aaron Cowen | 4,226,809 | $69,531,008 | +26% | 1.78% |
| 4. | Vestal Point Capital Ryan Wilder | 3,603,465 | $59,276,999 | +365% | 1.66% |
| 5. | Braidwell LP Alex Karnal | 3,206,574 | $52,748,142 | +239% | 1.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.84 | 10,000 | $58,383.00 | 10,000 | 2025-03-24 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.73 | 468 | $9,231.86 | 594,538 | 2026-06-01 | Filing | |
| $19.41 | 4,998 | $97,021.18 | 595,006 | 2026-06-01 | Filing | |
| $19.87 | 6,000 | $119,220.00 | 67,845 | 2026-05-29 | Filing | |
| $20.00 | 2,175 | $43,500.00 | 62,371 | 2026-05-27 | Filing | |
| $19.00 | 2,176 | $41,344.00 | 62,371 | 2026-05-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,692,298 | $126,538,302 | 7.19% | |
| 2. | 5,637,684 | $92,739,901 | 0% | |
| 3. | 4,622,151 | $76,034,384 | 2.18% | |
| 4. | 3,353,980 | $55,172,971 | 0% | |
| 5. | 3,180,780 | $52,323,831 | 37% |
News See All
Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) is among the best fast money stocks to buy now. During the second quarter, Pallas Capital Advisors acquired a new position in Monte Rosa Therapeutics, Inc.
11 Best Fast Money Stocks to Buy Now
In this fast-paced world, most people have become impatient. Everyone is drawn to whatever delivers quick results, whether it be fast fame or fast money.
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Monte Rosa Therapeutics Conference Call to discuss the company's pipeline updates and clinical results. At this time, all participants are in a listen-only mode.
Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies
In this article, we discuss the top 15 companies in Alphabet Inc (GOOGL)’s investment portfolio.
Hedge Fund Resource Center